Interaction Engagement, as Assessed by Interactions Completed
Primary
· At 8 weeks
Interactions Completed (interactions completed, range 0 to unbound)
| Group | Value | 95% CI |
|---|---|---|
| Experimental | 7.3 | 1 – 28 |
Last reviewed · How we verify
NCT05757453
Boost Study 31380 (mHealth)
Completed
Phase 1
Results posted
Last updated 18 December 2024
What this trial tests
Phase 1 trial testing mHealth in Addiction in 43 participants. Completed in 30 March 2023.
Timeline
18 April 2022
Primary endpoint
30 March 2023
30 March 2023
30 March 2023
Quick facts
| Lead sponsor | NXTech |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 43 |
| Start date | 18 April 2022 |
| Primary completion | 30 March 2023 |
| Estimated completion | 30 March 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- mHealth
Conditions studied
- Addiction — all drugs for Addiction →
Sponsor
NXTech
Who can join
Adults 18 to 65, any sex, with Addiction. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Intervention Usability Rating, as Assessed by Likert User Experience Scale
Secondary
· At 8 weeks
Subjective scoring of design and function usability, Likert User Experience Scale (score range 1-5, higher better)
| Group | Value | 95% CI |
|---|---|---|
| Experimental | 4.7 | 4 – 5 |
Treatment Progress Measure, as Assessed by TEA Score
Secondary
· At 8 weeks
Patient-Centered instrument for evaluating progress, TEA Score (scale range 4 to 40, higher better), assessed weekly for 8 weeks with week 8 reported
| Group | Value | 95% CI |
|---|---|---|
| Experimental | 19 | 15 – 36 |
Sponsor's own description
The purpose of this research is to examine the potential for a new software-based behavioral support approach, for individuals with opioid use disorder, as an addition to usual care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05757453
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of mHealth
Trials testing the same drug.
- NCT06921798 — Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program · NA · not yet recruiting
- NCT06499064 — EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM) · NA · not yet recruiting
- NCT06594328 — Effect of Text Message Interventions in Maintaining Gingival Health in Pregnant Women · NA · enrolling by invitation
- NCT06535867 — The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorde · recruiting
- NCT06409793 — Motivating Adolescent Fitness · NA · not yet recruiting
Other recruiting trials for Addiction
Currently open trials in the same condition.
- NCT06618755 — Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool · NA · recruiting
- NCT06973512 — HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided · NA · recruiting
- NCT06264895 — Protocol for a Low Threshold Exercise Intervention for Women Experiencing Homelessness and Addiction. · NA · active not recruiting
- NCT06187766 — Effects of Social Media Addiction on Physical Activity Level and Exercise Capacity in University Students · active not recruiting
- NCT06015893 — Semaglutide Therapy for Alcohol Reduction (STAR) · Phase 2 · recruiting
Other NXTech trials
Trials by the same sponsor.
- NCT05990335 — Boost Study 21270 (Cognition) · EARLY_PHASE1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT05757453 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NXTech
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05757453.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing